A comprehensive view of Vaccination / Immunization. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

CDC director endorses new guideline for adults aged 65 and older to receive updated 2023-2024 COVID-19 vaccine dose; people 65 years of age and older accounted for more than half of COVID-19 hospitalizations from October 2023 to December 2023

Petco Love's National Pet Vaccination Month in March Urges Pet Vaccinations to Save Pet Lives

Novavax Inc. Discloses Fourth Quarter Financials and Gains Strategic Advantage with ACIP's Endorsement for Additional Senior COVID-19 Vaccine Dose

Pfizer reports its bivalent vaccine ABRYSVO maintains high protective efficacy for both RSV A and RSV B disease in adults aged 60 or older through two seasons after one dose; RSV infections account for approximately 60,000-160,000 hospitalizations in US

Moderna to host fifth annual investor event for vaccines and business updates on March 27, 2024

Ask us about our Bioeconomy market view

Trending Chart

Interactive chart with headline count